Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility

Rare ginsenosides are found in ginseng and notoginseng, two medicinal plants widely used in China for treatment of cardiovascular diseases and type 2 diabetes. However, their pharmacological studies regarding myocardial fuel metabolism and insulin signaling are not clear. To explore the effect of a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Phytomedicine (Stuttgart) 2019-05, Vol.58, p.152745-152745, Article 152745
Hauptverfasser: Peng, Shuang, Wang, Yilei, Zhou, Ying, Ma, Tingting, Wang, Yapu, Li, Jia, Huang, Fang, Kou, Junping, Qi, Lianwen, Liu, Baolin, Liu, Kang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 152745
container_issue
container_start_page 152745
container_title Phytomedicine (Stuttgart)
container_volume 58
creator Peng, Shuang
Wang, Yilei
Zhou, Ying
Ma, Tingting
Wang, Yapu
Li, Jia
Huang, Fang
Kou, Junping
Qi, Lianwen
Liu, Baolin
Liu, Kang
description Rare ginsenosides are found in ginseng and notoginseng, two medicinal plants widely used in China for treatment of cardiovascular diseases and type 2 diabetes. However, their pharmacological studies regarding myocardial fuel metabolism and insulin signaling are not clear. To explore the effect of a rare ginsenoside-standardized extract (RGSE), derived from steamed notoginseng, on cardiac fuel metabolism and insulin signaling. We used palmitic acid (PA) to treat H9c2 cells in vitro and high fat diet (HFD) to mice to induce insulin resistance in vivo. In vitro, differentiated H9c2 cells were pretreated with RGSE, metformin, mildronate or dichloroacetate (DCA) and stimulated with PA. In vivo, mice were fed with HFD and received RGSE, metformin or DCA for 6 weeks. Protein expression was determined by Western blotting. Mitochondrial membrane potential (Δψm), glucose uptake and reactive oxygen species (ROS) production were measured by fluorescence labeling. Other assessments including oxygen consumption rate (OCR) were also performed. RGSE prevented PA-induced decrease in pyruvate dehydrogenase (PDH) activity and increase in carnitine palmitoyltransferase 1 (CPT1) expression, and ameliorated insulin-mediated glucose uptake and utilization in H9c2 cells. Metformin and mildronate exhibited similar effects. In vivo, RGSE counteracted HFD-induced increase in myocardial expression of p-PDH and CPT1 and ameliorated cardiac insulin signaling. Metformin and DCA also showed beneficial effects. Further study showed that RGSE decreased OCR and mitochondrial complex I activity in PA-treated H9c2 cells, reduced ROS production and relieved mitochondrial oxidative stress, thus decreased serine phosphorylation in IRS-1. RGSE ameliorated myocardial insulin sensitivity under conditions of lipid overload, which was tightly associated with the decrease in mitochondrial oxidative stress via modulating glucose and fatty acid oxidation. [Display omitted]
doi_str_mv 10.1016/j.phymed.2018.11.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2212727516</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0944711318305634</els_id><sourcerecordid>2212727516</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-2bc9676b8cea148630d094b9b1d506c2ab155703f90a68f7f0a2ac794bb4542c3</originalsourceid><addsrcrecordid>eNp9kMuKFEEQRRNRnHb0D0Ry6aZqIupdG0EGHwMDgii4S_IRNUaTVdlmVjX235tNz2xdxSLOjUscId4ilAjY3ezLw-_TTK6sAIcSsQTonokddjgUMLa_nosdjE1T9Ij1lXiV0h4Am7GHl-KqRoC2x3Ynjt91JPnAS6IlJHaUpJ7Jc4h6Jen5wE6GI0UftCt4cZslJ-dTsDo61l7m4OZ5kZESp1UvluSRtZyD27xeeXmQM63aBM9WTp7-smHP6-m1eDFpn-jN47wWPz9_-nH7tbj_9uXu9uN9YRsY1qIyduz6zgyWNDZDV4PLP5nRoGuhs5U22LY91NMIuhumfgJdadtnxDRtU9n6Wry_3D3E8GejtKqZkyXv9UJhS6qqsOqrvsUuo80FtTGkFGlSh8izjieFoM7G1V5djKuzcYWosvEce_fYsJnz7in0pDgDHy4A5T-PTFEly5RFOY5kV-UC_7_hHwcQlvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2212727516</pqid></control><display><type>article</type><title>Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility</title><source>Access via ScienceDirect (Elsevier)</source><creator>Peng, Shuang ; Wang, Yilei ; Zhou, Ying ; Ma, Tingting ; Wang, Yapu ; Li, Jia ; Huang, Fang ; Kou, Junping ; Qi, Lianwen ; Liu, Baolin ; Liu, Kang</creator><creatorcontrib>Peng, Shuang ; Wang, Yilei ; Zhou, Ying ; Ma, Tingting ; Wang, Yapu ; Li, Jia ; Huang, Fang ; Kou, Junping ; Qi, Lianwen ; Liu, Baolin ; Liu, Kang</creatorcontrib><description>Rare ginsenosides are found in ginseng and notoginseng, two medicinal plants widely used in China for treatment of cardiovascular diseases and type 2 diabetes. However, their pharmacological studies regarding myocardial fuel metabolism and insulin signaling are not clear. To explore the effect of a rare ginsenoside-standardized extract (RGSE), derived from steamed notoginseng, on cardiac fuel metabolism and insulin signaling. We used palmitic acid (PA) to treat H9c2 cells in vitro and high fat diet (HFD) to mice to induce insulin resistance in vivo. In vitro, differentiated H9c2 cells were pretreated with RGSE, metformin, mildronate or dichloroacetate (DCA) and stimulated with PA. In vivo, mice were fed with HFD and received RGSE, metformin or DCA for 6 weeks. Protein expression was determined by Western blotting. Mitochondrial membrane potential (Δψm), glucose uptake and reactive oxygen species (ROS) production were measured by fluorescence labeling. Other assessments including oxygen consumption rate (OCR) were also performed. RGSE prevented PA-induced decrease in pyruvate dehydrogenase (PDH) activity and increase in carnitine palmitoyltransferase 1 (CPT1) expression, and ameliorated insulin-mediated glucose uptake and utilization in H9c2 cells. Metformin and mildronate exhibited similar effects. In vivo, RGSE counteracted HFD-induced increase in myocardial expression of p-PDH and CPT1 and ameliorated cardiac insulin signaling. Metformin and DCA also showed beneficial effects. Further study showed that RGSE decreased OCR and mitochondrial complex I activity in PA-treated H9c2 cells, reduced ROS production and relieved mitochondrial oxidative stress, thus decreased serine phosphorylation in IRS-1. RGSE ameliorated myocardial insulin sensitivity under conditions of lipid overload, which was tightly associated with the decrease in mitochondrial oxidative stress via modulating glucose and fatty acid oxidation. [Display omitted]</description><identifier>ISSN: 0944-7113</identifier><identifier>EISSN: 1618-095X</identifier><identifier>DOI: 10.1016/j.phymed.2018.11.006</identifier><identifier>PMID: 31005715</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Metabolic flexibility ; Mitochondrial oxidative stress ; Myocardial insulin resistance ; Rare ginsenosides ; Reactive oxygen species</subject><ispartof>Phytomedicine (Stuttgart), 2019-05, Vol.58, p.152745-152745, Article 152745</ispartof><rights>2018</rights><rights>Copyright © 2018. Published by Elsevier GmbH.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-2bc9676b8cea148630d094b9b1d506c2ab155703f90a68f7f0a2ac794bb4542c3</citedby><cites>FETCH-LOGICAL-c408t-2bc9676b8cea148630d094b9b1d506c2ab155703f90a68f7f0a2ac794bb4542c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.phymed.2018.11.006$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,782,786,3552,27931,27932,46002</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31005715$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peng, Shuang</creatorcontrib><creatorcontrib>Wang, Yilei</creatorcontrib><creatorcontrib>Zhou, Ying</creatorcontrib><creatorcontrib>Ma, Tingting</creatorcontrib><creatorcontrib>Wang, Yapu</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><creatorcontrib>Huang, Fang</creatorcontrib><creatorcontrib>Kou, Junping</creatorcontrib><creatorcontrib>Qi, Lianwen</creatorcontrib><creatorcontrib>Liu, Baolin</creatorcontrib><creatorcontrib>Liu, Kang</creatorcontrib><title>Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility</title><title>Phytomedicine (Stuttgart)</title><addtitle>Phytomedicine</addtitle><description>Rare ginsenosides are found in ginseng and notoginseng, two medicinal plants widely used in China for treatment of cardiovascular diseases and type 2 diabetes. However, their pharmacological studies regarding myocardial fuel metabolism and insulin signaling are not clear. To explore the effect of a rare ginsenoside-standardized extract (RGSE), derived from steamed notoginseng, on cardiac fuel metabolism and insulin signaling. We used palmitic acid (PA) to treat H9c2 cells in vitro and high fat diet (HFD) to mice to induce insulin resistance in vivo. In vitro, differentiated H9c2 cells were pretreated with RGSE, metformin, mildronate or dichloroacetate (DCA) and stimulated with PA. In vivo, mice were fed with HFD and received RGSE, metformin or DCA for 6 weeks. Protein expression was determined by Western blotting. Mitochondrial membrane potential (Δψm), glucose uptake and reactive oxygen species (ROS) production were measured by fluorescence labeling. Other assessments including oxygen consumption rate (OCR) were also performed. RGSE prevented PA-induced decrease in pyruvate dehydrogenase (PDH) activity and increase in carnitine palmitoyltransferase 1 (CPT1) expression, and ameliorated insulin-mediated glucose uptake and utilization in H9c2 cells. Metformin and mildronate exhibited similar effects. In vivo, RGSE counteracted HFD-induced increase in myocardial expression of p-PDH and CPT1 and ameliorated cardiac insulin signaling. Metformin and DCA also showed beneficial effects. Further study showed that RGSE decreased OCR and mitochondrial complex I activity in PA-treated H9c2 cells, reduced ROS production and relieved mitochondrial oxidative stress, thus decreased serine phosphorylation in IRS-1. RGSE ameliorated myocardial insulin sensitivity under conditions of lipid overload, which was tightly associated with the decrease in mitochondrial oxidative stress via modulating glucose and fatty acid oxidation. [Display omitted]</description><subject>Metabolic flexibility</subject><subject>Mitochondrial oxidative stress</subject><subject>Myocardial insulin resistance</subject><subject>Rare ginsenosides</subject><subject>Reactive oxygen species</subject><issn>0944-7113</issn><issn>1618-095X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kMuKFEEQRRNRnHb0D0Ry6aZqIupdG0EGHwMDgii4S_IRNUaTVdlmVjX235tNz2xdxSLOjUscId4ilAjY3ezLw-_TTK6sAIcSsQTonokddjgUMLa_nosdjE1T9Ij1lXiV0h4Am7GHl-KqRoC2x3Ynjt91JPnAS6IlJHaUpJ7Jc4h6Jen5wE6GI0UftCt4cZslJ-dTsDo61l7m4OZ5kZESp1UvluSRtZyD27xeeXmQM63aBM9WTp7-smHP6-m1eDFpn-jN47wWPz9_-nH7tbj_9uXu9uN9YRsY1qIyduz6zgyWNDZDV4PLP5nRoGuhs5U22LY91NMIuhumfgJdadtnxDRtU9n6Wry_3D3E8GejtKqZkyXv9UJhS6qqsOqrvsUuo80FtTGkFGlSh8izjieFoM7G1V5djKuzcYWosvEce_fYsJnz7in0pDgDHy4A5T-PTFEly5RFOY5kV-UC_7_hHwcQlvA</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Peng, Shuang</creator><creator>Wang, Yilei</creator><creator>Zhou, Ying</creator><creator>Ma, Tingting</creator><creator>Wang, Yapu</creator><creator>Li, Jia</creator><creator>Huang, Fang</creator><creator>Kou, Junping</creator><creator>Qi, Lianwen</creator><creator>Liu, Baolin</creator><creator>Liu, Kang</creator><general>Elsevier GmbH</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190501</creationdate><title>Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility</title><author>Peng, Shuang ; Wang, Yilei ; Zhou, Ying ; Ma, Tingting ; Wang, Yapu ; Li, Jia ; Huang, Fang ; Kou, Junping ; Qi, Lianwen ; Liu, Baolin ; Liu, Kang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-2bc9676b8cea148630d094b9b1d506c2ab155703f90a68f7f0a2ac794bb4542c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Metabolic flexibility</topic><topic>Mitochondrial oxidative stress</topic><topic>Myocardial insulin resistance</topic><topic>Rare ginsenosides</topic><topic>Reactive oxygen species</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peng, Shuang</creatorcontrib><creatorcontrib>Wang, Yilei</creatorcontrib><creatorcontrib>Zhou, Ying</creatorcontrib><creatorcontrib>Ma, Tingting</creatorcontrib><creatorcontrib>Wang, Yapu</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><creatorcontrib>Huang, Fang</creatorcontrib><creatorcontrib>Kou, Junping</creatorcontrib><creatorcontrib>Qi, Lianwen</creatorcontrib><creatorcontrib>Liu, Baolin</creatorcontrib><creatorcontrib>Liu, Kang</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Phytomedicine (Stuttgart)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peng, Shuang</au><au>Wang, Yilei</au><au>Zhou, Ying</au><au>Ma, Tingting</au><au>Wang, Yapu</au><au>Li, Jia</au><au>Huang, Fang</au><au>Kou, Junping</au><au>Qi, Lianwen</au><au>Liu, Baolin</au><au>Liu, Kang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility</atitle><jtitle>Phytomedicine (Stuttgart)</jtitle><addtitle>Phytomedicine</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>58</volume><spage>152745</spage><epage>152745</epage><pages>152745-152745</pages><artnum>152745</artnum><issn>0944-7113</issn><eissn>1618-095X</eissn><abstract>Rare ginsenosides are found in ginseng and notoginseng, two medicinal plants widely used in China for treatment of cardiovascular diseases and type 2 diabetes. However, their pharmacological studies regarding myocardial fuel metabolism and insulin signaling are not clear. To explore the effect of a rare ginsenoside-standardized extract (RGSE), derived from steamed notoginseng, on cardiac fuel metabolism and insulin signaling. We used palmitic acid (PA) to treat H9c2 cells in vitro and high fat diet (HFD) to mice to induce insulin resistance in vivo. In vitro, differentiated H9c2 cells were pretreated with RGSE, metformin, mildronate or dichloroacetate (DCA) and stimulated with PA. In vivo, mice were fed with HFD and received RGSE, metformin or DCA for 6 weeks. Protein expression was determined by Western blotting. Mitochondrial membrane potential (Δψm), glucose uptake and reactive oxygen species (ROS) production were measured by fluorescence labeling. Other assessments including oxygen consumption rate (OCR) were also performed. RGSE prevented PA-induced decrease in pyruvate dehydrogenase (PDH) activity and increase in carnitine palmitoyltransferase 1 (CPT1) expression, and ameliorated insulin-mediated glucose uptake and utilization in H9c2 cells. Metformin and mildronate exhibited similar effects. In vivo, RGSE counteracted HFD-induced increase in myocardial expression of p-PDH and CPT1 and ameliorated cardiac insulin signaling. Metformin and DCA also showed beneficial effects. Further study showed that RGSE decreased OCR and mitochondrial complex I activity in PA-treated H9c2 cells, reduced ROS production and relieved mitochondrial oxidative stress, thus decreased serine phosphorylation in IRS-1. RGSE ameliorated myocardial insulin sensitivity under conditions of lipid overload, which was tightly associated with the decrease in mitochondrial oxidative stress via modulating glucose and fatty acid oxidation. [Display omitted]</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>31005715</pmid><doi>10.1016/j.phymed.2018.11.006</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0944-7113
ispartof Phytomedicine (Stuttgart), 2019-05, Vol.58, p.152745-152745, Article 152745
issn 0944-7113
1618-095X
language eng
recordid cdi_proquest_miscellaneous_2212727516
source Access via ScienceDirect (Elsevier)
subjects Metabolic flexibility
Mitochondrial oxidative stress
Myocardial insulin resistance
Rare ginsenosides
Reactive oxygen species
title Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T14%3A37%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rare%20ginsenosides%20ameliorate%20lipid%20overload-induced%20myocardial%20insulin%20resistance%20via%20modulating%20metabolic%20flexibility&rft.jtitle=Phytomedicine%20(Stuttgart)&rft.au=Peng,%20Shuang&rft.date=2019-05-01&rft.volume=58&rft.spage=152745&rft.epage=152745&rft.pages=152745-152745&rft.artnum=152745&rft.issn=0944-7113&rft.eissn=1618-095X&rft_id=info:doi/10.1016/j.phymed.2018.11.006&rft_dat=%3Cproquest_cross%3E2212727516%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2212727516&rft_id=info:pmid/31005715&rft_els_id=S0944711318305634&rfr_iscdi=true